AIADX
Price
$10.48
Change
-$0.18 (-1.69%)
Updated
Jun 9 closing price
Net Assets
1.99B
BFIAX
Price
$9.50
Change
+$0.02 (+0.21%)
Updated
Jun 9 closing price
Net Assets
13.18B
Interact to see
Advertisement

AIADX vs BFIAX

Header iconAIADX vs BFIAX Comparison
Open Charts AIADX vs BFIAXBanner chart's image
AIADX vs BFIAX Comparison Chart in %
View a ticker or compare two or three
VS
AIADX vs. BFIAX commentary
Jun 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIADX is a Hold and BFIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BFIAX has more cash in the bank: 13.2B vs. AIADX (1.99B). AIADX pays higher dividends than BFIAX: AIADX (4.48) vs BFIAX (3.26). AIADX was incepted earlier than BFIAX: AIADX (9 years) vs BFIAX (13 years). BFIAX (0.66) is less costly to investors than AIADX (0.29). AIADX is a more actively managed with annual turnover of: 44.00 vs. BFIAX (12.00). AIADX has a lower initial minimum investment than BFIAX: AIADX (0) vs BFIAX (250). AIADX annual gain was more profitable for investors over the last year : 5.04 vs. BFIAX (4.52). AIADX return over 5 years is better than : 4.72 vs. BFIAX (0.73).
AIADXBFIAXAIADX / BFIAX
Total Expense Ratio0.290.6644%
Annual Report Gross Expense Ratio0.290.6644%
Fund Existence9 years13 years-
Gain YTD1.1580.849136%
Front LoadN/A3%-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.99B13.2B15%
Annual Yield % from dividends4.483.26137%
Returns for 1 year5.044.52112%
Returns for 3 years11.9510.66112%
Returns for 5 years4.720.73648%
Returns for 10 yearsN/A22.19-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BMHL5.310.93
+21.23%
Bluemount Holdings Ltd
FIZZ37.191.43
+4.01%
National Beverage Corp
AWK125.533.04
+2.48%
American Water Works Company
GSM3.840.01
+0.26%
Ferroglobe PLC
ERNA6.80-0.59
-7.98%
Ernexa Therapeutics Inc.